| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.59 | 0.03 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.04 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |